Notes is dead! But not really - it can still benefit you!
September 28, 2017
Notes is dead! But not really - it can still benefit you!
Score 10 out of 10
Vetted Review
Overall Satisfaction with IBM Notes
Our organization is a small IBM Business Partner. We use Notes for email and application development. It provides us secure access and storage of our mail data. Since we are small, it's used across the organization. We can also do team scheduling through calendaring and/or custom applications. We also write business-critical applications in Notes and Domino for our customers.
- Calendar and Scheduling are extremely mature and implemented well.
- In general, email is email. Notes is the frontend just as Outlook would be. The presentation and implementation of the mail system are on par with any other vendor in the market.
- Although at certain points the integration could be tighter, Notes integrates well with the other IBM Collaboration products like Connections and Sametime. It is a single point of entry for enterprise collaboration.
- IBM need to solidify their roadmap for IBM Notes and work more on marketing the software.
- Lately, the fix packs (or feature packs) have had some bugs - more so than ones prior to the 9.0.1 version. This needs a little more attention.
- Though it is great with newer hardware, especially SSD, the Eclipse-based Notes Client can still be rather slow to load for some users.
- As we are a Partner, ROI is difficult to gauge as we use Notes not only for day-to-day work but also in R&D for customers.
- We are, however, able to relate to customers how Notes can best suit their needs due to how we have seen it meet our needs and the needs of other customers.
As I stated previously, mail is mail. Notes is a fantastic option as a frontend for mail. On top of that, a business can be built from the custom applications that can be developed in it. We do have gmail as an option, but the vast majority of users are on Notes. We also choose it because it's part of our core business model at the moment.